Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study was designed to compare and evaluate the pharmacokinetic characteristics of
febuxostat after single oral administration of TMX-67 (test drug) and Feburic® tablet in
healthy adults; and to evaluate safety and tolerance following a single-dose administration.